ES8801372A1 - Un metodo para preparar una vacuna contra el virus de la influenza equina. - Google Patents
Un metodo para preparar una vacuna contra el virus de la influenza equina.Info
- Publication number
- ES8801372A1 ES8801372A1 ES556256A ES556256A ES8801372A1 ES 8801372 A1 ES8801372 A1 ES 8801372A1 ES 556256 A ES556256 A ES 556256A ES 556256 A ES556256 A ES 556256A ES 8801372 A1 ES8801372 A1 ES 8801372A1
- Authority
- ES
- Spain
- Prior art keywords
- vaccines
- equine influenza
- methods
- eiv
- dna sequences
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/811—Peptides or proteins is immobilized on, or in, an inorganic carrier
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
METODO DE PREPARAR UNA VACUNA CONTRA EL VIRUS DE LA INFLUENCIA EQUINA. CONSISTE EN: A) CULTIVAR CELULAS HOSPEDANTES EN UN MEDIO NUTRIENTE, A UNA TEMPERATURA ENTRE LA AMBIENTE Y 40JC, HASTA OBTENER UNA GRAN POBLACION DE CELULAS, EN QUE LAS CELULAS HOSPEDANTES SE HAN TRANSFORMADO CON UNA SECUENCIA DE ADN RECOMBINANTE QUE CODIFICA UNA PROTEINA SELECCIONADA DEL GRUPO HEMAGLUTININA EQUINA H7, HEMAGLUTININA EQUINA H3, NEURAMINIDASA EQUINA N7 Y NEURAMINIDASA EQUINA N8, CUYA SECUENCIA CODIFICADORA ESTA BAJO EL CONTROL DE UN PROMOTOR INDUCIBLE; B) INDUCIR LA PRODUCCION DE LA PROTEINA CODIFICADORA PROVOCANDO LA ACTIVIDAD DEL PROMOTOR; Y C) SONDAR ANTES UNA GENOTECA DE ADNC, PROVENIENTE DE UN AISLADO RECIENTE DE EIV DE UN ANIMAL INFECTADO, CON UNA SONDA DERIVADA DE ADN SELECCIONADA DE LA SECUENCIA EQUINA H7. TIENE APLICACIONES EN EL CAMPO DE LA VETERINARIA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/747,020 US4631191A (en) | 1985-06-20 | 1985-06-20 | Methods and compositions useful in preventing equine influenza |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8801372A1 true ES8801372A1 (es) | 1987-12-16 |
ES556256A0 ES556256A0 (es) | 1987-12-16 |
Family
ID=25003339
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES556256A Expired ES8801372A1 (es) | 1985-06-20 | 1986-06-19 | Un metodo para preparar una vacuna contra el virus de la influenza equina. |
Country Status (5)
Country | Link |
---|---|
US (1) | US4631191A (es) |
EP (1) | EP0229826A4 (es) |
AU (1) | AU6125386A (es) |
ES (1) | ES8801372A1 (es) |
WO (1) | WO1986007593A1 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5866136A (en) * | 1986-08-01 | 1999-02-02 | Commonwealth Scientific And Industrial Organisation | Recombinant vaccine |
US5348741A (en) * | 1987-02-03 | 1994-09-20 | The United States Of America As Represented By The Department Of Health And Human Services | Vector for recombinant poxvirus expressing rabies virus glycoprotein |
WO1990002762A1 (en) | 1988-09-02 | 1990-03-22 | The Rockefeller University | Macrophage-derived inflammatory mediator (mip-2) |
ES2082850T3 (es) * | 1989-02-24 | 1996-04-01 | Univ California | Inmunoglobulinas preparadas geneticamente. |
US5643578A (en) | 1992-03-23 | 1997-07-01 | University Of Massachusetts Medical Center | Immunization by inoculation of DNA transcription unit |
US5620896A (en) * | 1992-03-23 | 1997-04-15 | University Of Massachusetts Medical Center | DNA vaccines against rotavirus infections |
US6165993A (en) * | 1992-03-23 | 2000-12-26 | University Of Massachusetts Medical Center | DNA vaccines against rotavirus infections |
US6485729B1 (en) * | 1993-09-13 | 2002-11-26 | Protein Sciences Corporation | Neuraminidase-supplemented compositions |
FR2751226B1 (fr) * | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies du cheval |
US6482414B1 (en) | 1998-08-13 | 2002-11-19 | The University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Cold-adapted equine influenza viruses |
US6579528B1 (en) | 1998-08-13 | 2003-06-17 | The University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Cold-adapted equine influenza viruses |
US6177082B1 (en) | 1998-08-13 | 2001-01-23 | The University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Cold-adapted equine influenza viruses |
US6249570B1 (en) * | 1999-06-08 | 2001-06-19 | David A. Glowny | System and method for recording and storing telephone call information |
CA2403979A1 (en) * | 2000-04-03 | 2001-10-11 | The University Of Pittsburgh Of The Commonwealth System Of Higher Education | Cold-adapted equine influenza viruses |
WO2005014778A2 (en) * | 2003-05-15 | 2005-02-17 | The Board Of Regents For Oklahoma State University | Dna vaccine expressing ha1 of equine-2 influenza virus |
US11865172B2 (en) | 2005-04-21 | 2024-01-09 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
US7959929B2 (en) | 2005-04-21 | 2011-06-14 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
US7682619B2 (en) | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
KR101123657B1 (ko) * | 2009-11-23 | 2012-03-20 | 최장호 | 근육운동기구 |
CN102180927A (zh) * | 2011-03-25 | 2011-09-14 | 中国人民解放军军事医学科学院微生物流行病研究所 | 获得流感样本中流感病毒核酸的方法及其专用引物 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4357421A (en) * | 1979-04-02 | 1982-11-02 | G. D. Searle & Co. | Synthetic gene coding for influenza hemagglutinin |
US4455142A (en) * | 1980-07-07 | 1984-06-19 | Alza Corporation | Method of coadministering an antigen and an immunopotentiator |
US4548814A (en) * | 1980-12-18 | 1985-10-22 | The Board Of Trustees Of The University Of Illinois | Composition of matter and process |
IL61904A (en) * | 1981-01-13 | 1985-07-31 | Yeda Res & Dev | Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same |
US4537769A (en) * | 1982-04-06 | 1985-08-27 | American Cyanamid Company | Stabilization of influenza virus vaccine |
DE3381376D1 (de) * | 1982-04-16 | 1990-05-03 | Cornell Res Foundation Inc | Temperaturempfindliche reassortierende viren und impfstoff gegen pferdeinfluenza. |
SE8205892D0 (sv) * | 1982-10-18 | 1982-10-18 | Bror Morein | Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin |
GB8300467D0 (en) * | 1983-01-08 | 1983-02-09 | Wellcome Found | Equine influenza |
-
1985
- 1985-06-20 US US06/747,020 patent/US4631191A/en not_active Expired - Fee Related
-
1986
- 1986-06-19 ES ES556256A patent/ES8801372A1/es not_active Expired
- 1986-06-20 WO PCT/US1986/001343 patent/WO1986007593A1/en not_active Application Discontinuation
- 1986-06-20 AU AU61253/86A patent/AU6125386A/en not_active Abandoned
- 1986-06-20 EP EP19860904557 patent/EP0229826A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP0229826A1 (en) | 1987-07-29 |
US4631191A (en) | 1986-12-23 |
ES556256A0 (es) | 1987-12-16 |
WO1986007593A1 (en) | 1986-12-31 |
AU6125386A (en) | 1987-01-13 |
EP0229826A4 (en) | 1989-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8801372A1 (es) | Un metodo para preparar una vacuna contra el virus de la influenza equina. | |
Wunner et al. | Antigenic variants of CVS rabies virus with altered glycosylation sites | |
DE69333397D1 (de) | Retro-, inverso-, und retro-inverso synthetische peptidanaloge | |
KR900700508A (ko) | 인간의 호흡기 합포체성 바이러스에 대한 당단백질 면역 단편을 함유하는 키메라(chimeric) 당단백질 | |
SE9004010D0 (sv) | Viralt medel | |
MY103182A (en) | Vaccines against acquired immune deficiency syndrome. | |
EP0414689A4 (en) | Pox virus vectors | |
NO852567L (no) | Thymopentinanaloger og fremgangsmmaate for deres fremstilling. | |
ES8500997A1 (es) | Un metodo para producir un peptido. | |
HUP0002472A2 (hu) | Izolált dendritikus sejtmembrán-fehérje gének | |
ZA936970B (en) | Anti-feline immunodeficiency virus (FIV) vaccines | |
KR890700030A (ko) | 인플루엔자균(Haemophilus influenzae)의 백신 및 진단방법 | |
DK11187D0 (da) | Dna-sekvenser der koder for proteiner med husi-type i inhibitorers biologiske aktivitet, biotekniske fremgangsmaader til fremstilling af proteinerne o g farmaceutiske praeparater der indeholder dem | |
ATE101200T1 (de) | Impfstoffe gegen menschliche respiratorische viren. | |
IE870507L (en) | Bovine virus diarrhea and hog cholera vaccines | |
HUP9901005A2 (hu) | Herpeszvírusok RFHV/KSHV-alcsaládjába tartozó vírusokból származó glikoprotein-B | |
Stampfer et al. | Identification of the vesicular stomatitis virus large protein as a unique viral protein | |
NO984491L (no) | SCF-analogpreparater og fremgangsmÕte for fremstilling av disse | |
Kos et al. | Induction of primary anti‐viral cytotoxic T cells by in vitro stimulation with short synthetic peptide and interleukin‐7 | |
DE68923286D1 (de) | Impfstoffe und testsätze für haemophilus influenzae. | |
NZ507983A (en) | A polypeptide comprising the amino acid of an n- terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof | |
ES8800358A1 (es) | Un procedimiento para preparar un polipeptido hibrido. | |
Roy | Phosphoproteins of spring viremia of carp virus | |
Irving et al. | Shedding of vesicular stomatitis virus soluble glycoprotein by removal of carboxy-terminal peptide | |
Kotwal et al. | Viral membrane glycoproteins: Comparison of the amino acid terminal amino acid sequences of the precursor and mature glycoproteins of three serotypes of vesicular stomatitis virus |